INS and obesity disorder: As shown in Figure 2B, Tan I-treated HFD-induced obese mice demonstrated a higher sensitivity to insulin administration, compared to HFD-induced obese mice not treated with Tan I. Taken together, these results indicated that Tan I significantly prevented HFD-induced obesity and improved glucose utilization and insulin sensitivity.